Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GR 103545

Known as: GR-103545, GR103545 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
1. Jaffe AE, Irizarry RA. Accounting for cellular heterogeneity is critical in epigenomewide association studies. Genome Biol… Expand
  • figure 1
2013
2013
The κ-opioid receptors (KOR) are involved in mood disorders and addictive conditions. In vivo imaging studies of this receptor in… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
2011
2011
INTRODUCTION GR103545 is a potent and selective kappa-opioid receptor agonist. Previous studies in non-human primates… Expand
  • figure 1
  • table 1
2007
2007
LY255582 is a pan opioid selective receptor antagonist that has been shown to have high affinity for mu, delta, and kappa… Expand
Highly Cited
2005
Highly Cited
2005
UNLABELLED Brain kappa-opioid receptors (ORs) may be involved in several pathologic conditions, such as addiction, psychosis, and… Expand
2002
2002
The R and S enantiomers of [(11)C]GR89696, [(11)C]-methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)methyl]-1… Expand
1993
1993
1 The evidence for κ‐receptor heterogeneity is equivocal. We have now investigated this question by comparing the effects of five… Expand
1993
1993
1 Effects of the α2‐adrenoceptor agonists, UK14304 and clonidine, the 5‐HT1 receptor agonist, sumatriptan and the κ‐opioid… Expand
1992
1992
1 The pharmacological profile of GR94839, a κ‐opioid agonist with limited access to the central nervous system, has been… Expand
1990
1990
1. This paper describes the opioid receptor pharmacology and in vivo activity of several novel benzene-acetamidopiperidine and… Expand